Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Colon Cancer Genomics

Clinical Trials

    • Cancer(4)
  • Colorectal Cancer, Sarcoma Cancers, Stomach and Esophagus, Kidney Cancer, Head and Neck Cancers, Liver Cancer, Lung Cancer, Gynecological Cancers, Pancreatic Cancer, Prostate Cancer, Thyroid and Other Endocrine Cancers, Breast Cancer

    PROgram to address psychosocial Support, clinical outcomes, and genomic insights for Patients with EaRly onset cancers

    • Colorectal Cancer

      A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

      • Phase 1 Cancers

        A Phase 1a/1b Study of LY3537982 in Patients With KRAS G12C-Mutant Advanced Solid Tumors

        • Phase 1 Cancers

          A Phase 1 Trial Evaluating the Safety, Tolerability, PK, and Efficacy of QTX3034 in Patients With Solid Tumors With KRASG12D Mutation

          • About Us
          • Contact Us
          • Donate
          • Referring Doctors
          • Clinical Keywords

          333 Cedar St.

          New Haven, CT 06510

          • Yale School of Medicine
          • Yale University
          • Terms & Privacy Policies
          • Accessibility at YSM
          • Patient Rights
          • HIPAA at Yale
          • Non-discrimination Statement
          Copyright 2025 Yale Medicine